Vildagliptin ameliorates oxidative stress and pancreatic beta cell destruction in type 1 diabetic rats.

Simple item page
dc.contributor.authorÁvila, Danielle de Lima
dc.contributor.authorAraújo, Glaucy Rodrigues de
dc.contributor.authorSilva, Maísa
dc.contributor.authorMiranda, Pedro Henrique de Amorim
dc.contributor.authorDiniz, Mirla Fiuza
dc.contributor.authorPedrosa, Maria Lúcia
dc.contributor.authorSilva, Marcelo Eustáquio
dc.contributor.authorLima, Wanderson Geraldo de
dc.contributor.authorCosta, Daniela Caldeira
dc.date.accessioned2014-12-16T23:34:53Z
dc.date.available2014-12-16T23:34:53Z
dc.date.issued2013
dc.description.abstractBackground and Aims. It is believed that oxidative stress plays a role in the pathogenesis of diabetes mellitus. Several strategies have been developed with the objective of minimizing diabetic complications. Among these, inhibitors of dipeptidyl peptidase-IV (DPP-IV), which act by blocking degradation of incretin hormones, glucagon-like peptide hormone (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), have been the focus of many studies. It is known that, among the effects of incretins, we highlight its insulinotropic and cytoprotective effects on pancreatic b-cells. The objective of this study was to evaluate the possible protective effects of treatment with vildagliptin, a DPP-IV inhibitor, in b-cells in an experimental model of type 1 diabetes induced by streptozotocin (STZ). Methods. Rats were treated for 4 weeks with vildagliptin at concentrations of 5 and 10 mg/kg. In order to observe the pancreatic damage and the possible protective effects of vildagliptin treatment, we measured stress markers TBARS and protein carbonyl, antioxidant enzymes SOD and catalase, and analyzed pancreatic histology. Results. The treatment was effective in modulating stress in pancreatic tissue, both by reducing levels of stress markers as well as by increasing activity of SOD and catalase. After analyzing the pancreatic histology, we found that vildagliptin was also able to preserve islets and pancreatic b-cells, especially at the concentration of 5 mg/kg. Conclusion. Thus, our results suggest that vildagliptin ameliorates oxidative stress and pancreatic beta cell destruction in type 1 diabetic rats. However, to evaluate the real potential of this medication in type 1 diabetes, further studies are needed.pt_BR
dc.identifier.citationÁVILA, D. L. et al. Vildagliptin ameliorates oxidative stress and pancreatic beta cell destruction in type 1 diabetic rats. Archives of Medical Research, p. 194-202, 2013. Disponível em: <http://www.sciencedirect.com/science/article/pii/S0188440913000751>. Acesso em: 08 nov. 2014.pt_BR
dc.identifier.doihttps://doi.org/10.1016/j.arcmed.2013.03.004
dc.identifier.issn0188-4409
dc.identifier.urihttp://www.repositorio.ufop.br/handle/123456789/4184
dc.language.isoen_USpt_BR
dc.rights.licenseO periódico Archives of Medical Research concede permissão para depósito deste artigo no Repositório Institucional da UFOP. Número da licença: 3520371332132.pt_BR
dc.subjectPancreaspt_BR
dc.subjectOxidative stresspt_BR
dc.subjectAntioxidantpt_BR
dc.titleVildagliptin ameliorates oxidative stress and pancreatic beta cell destruction in type 1 diabetic rats.pt_BR
dc.typeArtigo publicado em periodicopt_BR
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ARTIGO_VildagliptinAmelioratesOxidative.pdf
Size:
1.21 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.57 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
DECBI - Artigos publicados em periódicos